Guardant Health, Inc. - Common Stock (GH)

CUSIP: 40131M109

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock
Shares outstanding
123,850,680
Total 13F shares
131,043,779
Share change
+7,567,786
Total reported value
$13,383,522,775
Put/Call ratio
51%
Price per share
$102.14
Number of holders
490
Value change
+$814,275,136
Number of buys
275
Number of sells
181

Quarterly Holders Quick Answers

What is CUSIP 40131M109?
CUSIP 40131M109 identifies GH - Guardant Health, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Guardant Health, Inc. - Common Stock (GH) as of Q4 2025

As of 31 Dec 2025, Guardant Health, Inc. - Common Stock (GH) was held by 490 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 131,043,779 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/, Invesco Ltd., BAILLIE GIFFORD & CO, Capital International Investors, FRANKLIN RESOURCES INC, GEODE CAPITAL MANAGEMENT, LLC, Deep Track Capital, LP, and STATE STREET CORP. This page lists 490 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.